Ellen Linnea Freese Ballegaard, 1,2, Nicholas Carlson, 1, Morten Buus Jørgensen, 1, Ida Maria Hjelm Sørensen, 1, Helene Trankjær, 1, Anna Birna Almarsdóttir, 3, Susanne Bro, 1, Bo Feldt-Rasmussen, 1,2, Anne-Lise Kamper for The Copenhagen CKD Cohort Study Group 1
1 Department of Nephrology, Rigshospitalet, University of Copenhagen, Denmark
2 Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark
3 Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
Correspondence to: Ellen Linnea Freese Ballegaard; E-mail: ellen.linnea.freese.ballegaard@regionh.dk
Background Although cardiovascular morbidity and mortality are substantial in patients with chronic kidney disease (CKD), guideline-directed treatment of cardiovascular risk factors remains a challenge.
Methods Observational, cross-sectional study including patients aged 30–75 years with CKD stage 1–5 without kidney replacement therapy from a tertiary hospital outpatient clinic. Data was obtained through patient interview, clinical examination,...